- We have a large range of therapies planned for the next two announcements that did not fit on the previous list. It goes, among others o treating multiple sclerosis and completing the drug program for atopic dermatitis. A lot will also happen in oncology and hematology. From January 1, there will be renewals and new indications in lung cancer. We will also try to implement several new therapies in breast cancer, says Deputy Health Minister Maciej Miłkowski in an interview with Medexpress. As he adds, if it is not possible to introduce all the planned changes in the next two reimbursement lists, they will be proposed in the next ones.
LUNG CANCER
Lung cancer is the most common malignant neoplasm in Poland and the first cause of death from neoplastic diseases. The treatment of choice for patients diagnose...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
